UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Brentuximab vedotin in refractory CD30+ lymphomas: a bridge to allogeneic transplantation in approximately one quarter of patients treated on a Named Patient Programme at a single UK center

Haematologica (Roma), 2013-04, Vol.98 (4), p.611-614

2013

Volltextzugriff (PDF)

Outcomes after chimeric antigen receptor T-cell therapy across large B-cell lymphoma subtypes

Haematologica (Roma), 2024-08, Vol.109 (8), p.2716

2024

Volltextzugriff (PDF)

Bendamustine can be a bridge to allogeneic transplantation in relapsed Hodgkin lymphoma refractory to brentuximab vedotin

British journal of haematology, 2017-12, Vol.179 (5), p.841-843

2017

Volltextzugriff (PDF)

Preclinical and Early Clinical Results Indicate a Role for the Oral p300/CBP Inhibitor Inobrodib (CCS1477) in T-Cell Lymphoma

Blood, 2023-11, Vol.142 (Supplement 1), p.5795-5795

2023

Volltextzugriff (PDF)

Treatment Patterns and Outcomes in Patients with Relapsed/Refractory Follicular Lymphoma Who Received Third Line Therapy at the Christie NHS Foundation Trust in the UK

Blood, 2021-11, Vol.138 (Supplement 1), p.5011-5011

2021

Volltextzugriff (PDF)

Bendamustine can be a bridge to allogeneic transplantation inￂ relapsed Hodgkin lymphoma refractory to brentuximab vedotin

British journal of haematology, 2017-12, Vol.179 (5), p.841

2017

Volltextzugriff (PDF)

Results of a UK National Cancer Research Institute Phase II study of brentuximab vedotin using a response‐adapted design in the first‐line treatment of patients with classical Hodgkin lymphoma unsuitable for chemotherapy due to age, frailty or comorbidity (BREVITY)

British journal of haematology, 2021-04, Vol.193 (1), p.63-71

2021

Volltextzugriff (PDF)

Treatment Patterns and Outcomes in Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma: Experience from a Single UK Centre

Blood, 2019-11, Vol.134 (Supplement_1), p.2917-2917

2019

Volltextzugriff (PDF)

Treatment patterns and outcomes of unfit and elderly patients with Mantle cell lymphoma unfit for standard immunochemotherapy: A UK and Ireland analysis

British journal of haematology, 2021-07, Vol.194 (2), p.365-377

2021

Volltextzugriff (PDF)

Results of a multicentre UK‐wide retrospective study evaluating the efficacy of brentuximab vedotin in relapsed, refractory classical Hodgkin lymphoma in the transplant naive setting

British journal of haematology, 2017-11, Vol.179 (3), p.471-479

2017

Volltextzugriff (PDF)

Risk of Fracture Following Front Line R-CHOP Immunochemotherapy in Older Patients with Diffuse Large B Cell Lymphoma Is Common

Blood, 2019-11, Vol.134 (Supplement_1), p.1615-1615

2019

Volltextzugriff (PDF)

Burkitt's lymphoma of an ileal pouch following restorative proctocolectomy

Inflammatory bowel diseases, 2012-08, Vol.18 (8), p.E1596-E1597

2012

Volltextzugriff (PDF)

Gamma–delta T-cell lymphoma of skin, eye and brain presenting with visual loss

BMJ case reports, 2017-06, Vol.2017, p.bcr-2017-219946

2017

Volltextzugriff (PDF)

Outcomes following front-line chemotherapy in peripheral T-cell lymphoma: 10-year experience at The Royal Marsden and The Christie Hospital

Leukemia & lymphoma, 2018-07, Vol.59 (7), p.1586-1595

2018

Volltextzugriff (PDF)

Safety of bendamustine for the treatment of indolent non-Hodgkin lymphoma: a UK real-world experience

Blood advances, 2024-02, Vol.8 (4), p.878-888

2024

Volltextzugriff (PDF)

Allogeneic transplant following brentuximab vedotin in patients with relapsed or refractory Hodgkin lymphoma and systemic anaplastic large cell lymphoma

Leukemia & lymphoma, 2015-03, Vol.56 (3), p.703-710

2015

Volltextzugriff (PDF)

Ibrutinib as first-line therapy for mantle cell lymphoma: a multicenter, real-world UK study

Blood advances, 2024-03, Vol.8 (5), p.1209-1219

2024

Volltextzugriff (PDF)

Improved Survival in Peripheral T-Cell Lymphoma (PTCL) Following Complete Response to First-Line Chemotherapy: 10 Year Experience at the Royal Marsden and the Christie Hospitals 2002-2012

Blood, 2015-12, Vol.126 (23), p.1499-1499

2015

Volltextzugriff (PDF)

Fractures are common within 18 months following first-line R-CHOP in older patients with diffuse large B-cell lymphoma

Blood advances, 2020-09, Vol.4 (18), p.4337-4346

2020

Volltextzugriff (PDF)

Profile of brentuximab vedotin and its potential in the treatment of relapsed or refractory Hodgkin lymphoma

Blood and lymphatic cancer, 2012-05, Vol.2 (default), p.99-107

Illidge, Tim

2012

Volltextzugriff (PDF)

Burkitt's lymphoma of an ileal pouch following restorative proctocolectomy

Inflammatory bowel diseases, 2012, Vol.18 (8), p.E1596-E1597

2012

Volltextzugriff (PDF)

Allogeneic transplant following brentuximab vedotin in patients with relapsed or refractory Hodgkin lymphoma and systemic anaplastic large cell lymphoma

Leukemia & Lymphoma, 2015, Vol.56 (3), p.703-710

2015

Volltextzugriff (PDF)

A Corticostriatal Path Targeting Striosomes Controls Decision-Making under Conflict

Cell, 2015-06, Vol.161 (6), p.1320-1333

2015

Volltextzugriff (PDF)

Chronic Stress Alters Striosome-Circuit Dynamics, Leading to Aberrant Decision-Making

Cell, 2017-11, Vol.171 (5), p.1191-1205.e28

2017

Volltextzugriff (PDF)

1 – 25 von 237

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(197)
Mit Volltextzugriff
(199)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

Englisch
(236)
Portugiesisch
(1)

Erscheinungsjahr

n.n

Thema

Science & Technology
(161)
Humans
(133)
Life Sciences & Biomedicine
(120)
Male
(64)
Female
(61)
Adult
(46)
Middle Aged
(42)
Covid-19
(35)
Aged
(31)
Sars-Cov-2
(27)
Infectious Diseases
(25)
Severe Acute Respiratory Syndrome Coronavirus 2
(25)
Treatment Outcome
(25)
General & Internal Medicine
(24)
Viral Diseases
(24)
Disease Transmission
(23)
Epidemics
(22)
Physical Sciences
(22)
Medicine, General & Internal
(21)
Pandemics
(21)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(5)

Menü

Weitere Dienste

Einstellungen

Brentuximab vedotin in refractory CD30+ lymphomas: a bridge to allogeneic transplantation in approximately one quarter of patients treated on a Named Patient Programme at a single UK center

Outcomes after chimeric antigen receptor T-cell therapy across large B-cell lymphoma subtypes

Bendamustine can be a bridge to allogeneic transplantation in relapsed Hodgkin lymphoma refractory to brentuximab vedotin

Preclinical and Early Clinical Results Indicate a Role for the Oral p300/CBP Inhibitor Inobrodib (CCS1477) in T-Cell Lymphoma

Treatment Patterns and Outcomes in Patients with Relapsed/Refractory Follicular Lymphoma Who Received Third Line Therapy at the Christie NHS Foundation Trust in the UK

Bendamustine can be a bridge to allogeneic transplantation inￂ relapsed Hodgkin lymphoma refractory to brentuximab vedotin

Results of a UK National Cancer Research Institute Phase II study of brentuximab vedotin using a response‐adapted design in the first‐line treatment of patients with classical Hodgkin lymphoma unsuitable for chemotherapy due to age, frailty or comorbidity (BREVITY)

Treatment Patterns and Outcomes in Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma: Experience from a Single UK Centre

Treatment patterns and outcomes of unfit and elderly patients with Mantle cell lymphoma unfit for standard immunochemotherapy: A UK and Ireland analysis

Results of a multicentre UK‐wide retrospective study evaluating the efficacy of brentuximab vedotin in relapsed, refractory classical Hodgkin lymphoma in the transplant naive setting

Risk of Fracture Following Front Line R-CHOP Immunochemotherapy in Older Patients with Diffuse Large B Cell Lymphoma Is Common

Burkitt's lymphoma of an ileal pouch following restorative proctocolectomy

Gamma–delta T-cell lymphoma of skin, eye and brain presenting with visual loss

Outcomes following front-line chemotherapy in peripheral T-cell lymphoma: 10-year experience at The Royal Marsden and The Christie Hospital

Safety of bendamustine for the treatment of indolent non-Hodgkin lymphoma: a UK real-world experience

Allogeneic transplant following brentuximab vedotin in patients with relapsed or refractory Hodgkin lymphoma and systemic anaplastic large cell lymphoma

Ibrutinib as first-line therapy for mantle cell lymphoma: a multicenter, real-world UK study

Treatment outcomes in patients with large B‐cell lymphoma after progression to chimeric antigen receptor T‐cell therapy

Improved Survival in Peripheral T-Cell Lymphoma (PTCL) Following Complete Response to First-Line Chemotherapy: 10 Year Experience at the Royal Marsden and the Christie Hospitals 2002-2012

Fractures are common within 18 months following first-line R-CHOP in older patients with diffuse large B-cell lymphoma

Profile of brentuximab vedotin and its potential in the treatment of relapsed or refractory Hodgkin lymphoma

Burkitt's lymphoma of an ileal pouch following restorative proctocolectomy

Allogeneic transplant following brentuximab vedotin in patients with relapsed or refractory Hodgkin lymphoma and systemic anaplastic large cell lymphoma

A Corticostriatal Path Targeting Striosomes Controls Decision-Making under Conflict

Chronic Stress Alters Striosome-Circuit Dynamics, Leading to Aberrant Decision-Making

Suchergebnisse filtern